Introduction
Only a small portion of several hundred thousands of secondary metabolites isolated from various natural sources described to date in the literature has a macrocyclic structure. However, it is among them were identified compounds with potent antibiotic (antimicrobial, antiviral, antiparasitic) and antitumor activity. [1] Modern practical medicine successfully employs pharmaceutical preparations with oxygen and nitrogen containing macrocyclic compounds as drug substances, therefore recently the synthesis of macroheterocycles is one of the areas of obtaining of the materials with desired properties. [2] This is due to the relentless attention of chemists, biochemists and pharmacologists to this class of natural metabolites and synthetic derivatives, and the search for the optimal and efficient methods for the synthesis of optically active macrolide is relevant.
Availability of optically pure methyl (R,Z)-(+)-12-hydroxy-9-octadecenoic (ricinoleic) acid from castor oil, [3] as well as the presence of the Z-(C-9-C-10) double bond determine its widespread use as a promising substrate for chiral polyfunctional compounds. However, in the synthesis of macrocyclic compounds containing ester and hydrazide groups it has not yet been used.
Experimental Procedure
IR spectra in thin layers were recorded on a Shimadzu Prestige-21 IR instrument. NMR spectra in CDCl 3 with TMS internal standard were recorded on a Bruker AM-300 spectrometer (operating frequency 300. 3 CN at flow rate of 60 ml/min) using electrospray ionization (ESI) with simultaneous recording of positive and negative ions at the potentials of the capillary respectively, 4.5 kV and -3.5 kV. Capillary interface temperature 230ºC. Nebulizer gas flow (dried nitrogen) 1.5 l/min. HPLC analyses were carried out in a Shimadzu-LC-20AD with an SPD-M20A diode-matrix detector (Shimadzu, Japan) using a Phenomenex column (250×4.6 mm) and Luna C18 sorbent with particle size 5 m. The mobile phase was H 2 O:CH 3 CN at flow rate 1 ml/min. The analytical wavelength was 215 nm. [3] and 0.018 g (0.15 mmol) of 4-dimethylaminopyridine (DMAP) in 3 ml of abs. pyridine we added the solution of 1.5 mmol glutaric or adipic acid chloride in 1 ml of abs. diethyl ether. In 48 hours (with TLC control) the reaction mixture was diluted with 10 ml diethyl ether, sequentially rinsed with 5-pc HCl (3×1.5 ml) and saturated NaCl solution (3×1.5 ml), desiccated with MgSO 4 and sublimed. The residue was chromatographed (SiO 2 , petroleum ether -Et 2 O, 5:2), and the appropriate tetraester was prepared. 
Methyl (9Z,12R)-12-hydroxyoctadec-9-enoate (2). 1 Н NMR (СDCl

Bis-((9Z,12R)-1-methoxy-1-oxooctadec-9-en-12-yl)-1,3-pentane dicarboxylate (3)
.
Bis-((9Z,12R)-1-methoxy-1-oxooctadec-9-en-12-yl)-1,4-hexane dicarboxylate (4). Yield 1.20 g (68 %), R f 0.75 (MTBE).
[α] D 20 +130º (c 0.22, CH 2 Cl 2 ).
1 Н NMR (СDCl 3 ) δ ppm: 0.87 (6H, t, J = 6.7, H-18'), 1.22-1.37 (32Н, m, Н-4'÷Н-7', H-14'÷H-17'), 1.43-1.48 (4H, m, H-13'), 1.46-1.50 (4H, m, Н-3, Н-4), 1.57-1.61 (4H, m, H-3'), 1.90-1.98 (4H, m, H-8'), 2.18-2.23 (4H, m, H-11'), 2.15 (4H, t, J = 7.2, Н-2, H-5), 2.21 (4Н, t, J = 6.9, H-2'), 3.28-3.33 (2H, m, H-12'), 3.58 (6H, s, ОСН 3 ), 5.27 (2H, dt, J = 10.5, 6.3, H-10'), 5.38 (2Н, dtt, J = 10.8, 7.2, 1.4, H-9').
13 С NMR (СDCl 3 ) δ ppm: 13.77 (q, C-18'), 22.34 (t, C-17'), 24.65 (t, C-3, C-4), 25.30 (t, C-3'), 27.28 (t, C-8'), 29.05 (t, C-5', C-6', C-14'), 29.31 (t, C-15'), 29.46 (t, C-7'), 29.64 (t, C-4'), 31.50 (t, C-16'), 33.38 (t, C-13'), 33.57 (t, C-11'), 33.66 (t, (9R,11Z,31Z,34R)-9,34-dihexyl-1,8-dioxy-21,22-diazacyclotetratriacont-11,31-dien-2,7 ,20,23-tetraone (5) . To the solution of tetraester 4 (0.72 g, 1.0 mmol) in 8.5 ml of abs. dioxane we slowly added dropwise 0.05 g (1.0 mmol) 98-pc hydrazine hydrate under intensive stirring and stirred for 24 hours (with TLC control). Thereafter, dioxane was sublimed, and the residue was dissolved in 10 ml CH 2 Cl 2 , rinsed with water (3×3 ml), desiccated with MgSO 4 and sublimed. To the resultant residue we sequentially added 1 ml of abs. CH 2 Cl 2 and 10 ml of hexane under stirring and left to stand until the layers separated, the upper one being decanted. 
Results and Discussion
We have previously developed [4] enantiopure methyl and isopropyl-substituted 21-membered macrolide with hydrazide (-С(О)-NH-NH-C(O)-) and ester fragments on the basis of l-menthol using sequential [2+1]-condensation reactions of (3R,6S)-6-hydroxy-3,7-dimethyl octanoic methyl ether with glutaric dichloranhydride and [1+1]-condensation reaction with hydrazine hydrate. The synthesis of a macrocycle containing a similar hydrazide fragment on the basis of isosteviol was given in [5] . This paper considers a short-time expedient synthesis method for enantiopure 34-membered macrolide 5 from ricinoleic methyl ether obtained through re-etherification of castor oil with methanol. The macrolide contains a hydrazide function, two double bonds and two ether groups and has potential biological activity and complex-forming properties.
By Enantiomerically Pure Macroheterocycle with Ester and Hydrazide Groups glutaric or adipic chloranhydrides, we have produced, with high yields, bis-derivatives 3, 4, in which two hydroxyether carbon skeletons (2) at the С-12 position are linked together via diether spacers. The [1+1]-condensation of tetraesters (3, 4) with hydrazine hydrate was carried out at room temperature under high-rate dissolution conditions in 1,4-dioxane. In the case of using bis-derivative 4, the reaction was accompanied by the formation of the macrocycle 5 with two ester and hydrazide fragments. Nevertheless, tetraester (3) cyclization has not met with success.
The structures of the obtained products (3, 4) and the macrolide (5) have been confirmed by IR, 1 Н and
13
С NМR spectroscopy and chromato-mass spectrometry.
